Series A - Kurome Therapeutics
Investment Firm
Overview
Kurome Therapeutics is a preclinical stage company focused on subverting cancer's ability to evade therapy.
Announced Date
Jun 10, 2021
Funding Type
Series A
Highlights
Location
United States, North America
Social
Participant Investors
3
| Investor Name |
|---|
 Queen City Angels |
 Medicxi |
Round Details and Background
Kurome Therapeutics raised $15000000 on 2021-06-10 in Series A
Kurome Therapeutics is a preclinical stage company focused on subverting cancer's ability to evade therapy.
Company Funding History
2
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jun 10, 2021 |  Series A - Kurome Therapeutics | 4 | - | 15.0M |
| Apr 29, 2020 | Seed Round - Kurome Therapeutics | 1 | - | undefined |
Recent Activity
There is no recent news or activity for this profile.